Summary
The survival of grafts of dissociated allogeneic fetal neural dopamine (DA) rich tissue in the striatum has been studied after transplantation between inbred strains of mice differing at defined immunogenetical loci between donor and recipient. Six to 7 weeks and 15 weeks after grafting, surviving grafted DA neurons were found in the brains of all the recipients, albeit with a large variation in numbers, located either within the striatum or within the adjacent lateral ventricle. The mean number of surviving DA neurons did not differ between the syngeneic controls and the histoincompatible donor-host combinations, and there was no difference in survival between grafts that differed at single or multiple major histocompatibility complex (MHC) loci, and those that differed at multiple non-MHC loci. The amount of inflammatory cells in the graft area did not differ between the groups, and none of the animals showed massive infiltration of inflammatory cells. The in situ immunogenicity of the grafted neural tissue after intracerebral implantation was monitored by means of Simonsen's alloimmunization test, at 6–7 weeks after transplantation, which provides a sensitive measure primarily of the cellular immunological response. Most, but not all, graft recipients showed immunization with a Spleen Index (S.I.) close to that seen in recipients of an orthotopical skin graft of the same histoincompatibility combination. In contrast to the prolonged survival of the intracerebral neural transplants, none of the skin grafts survived longer than 3 weeks, thus demonstrating the immunologically privileged status of the brain. We conclude that intracerebrally grafted allogeneic neural tissue is capable of provoking a cellular immune response. Despite host immunization, however, the dissociated fetal neural allografts survived for at least 15 weeks without any overt signs of rejection, regardless of the donor-host combination used.
Similar content being viewed by others
References
Abercrombie M (1946) Estimation of nuclear population from microtome sections. Anat Rec 94: 239–247
Bakay RA, Fiandaca MS, Barrow DL, Schiff A, Collins DC (1985) Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates. Appl Neurophysiol 48: 358–361
Bankiewicz KS, Jacobowitz DM, Plunkett RJ, Oldfield EH, Kopin IJ (1987) Injury induced sprouting into the caudate nucleus, after solid tissue implantation in MPTP-induced parkinsonian monkeys. Soc Neurosci Abstr 46.16
Barker CF, Billingham RE (1977) Immunologically privileged sites. Adv Immunol 25: 1–54
Billingham RE, Medawar PB (1951) The technique of free skin grafting in mammals. J Exp Biol 28: 385–390
Björklund A, Stenevi U (1984) Intracerebral neuronal implants: neuronal replacement and reconstruction of damaged circuitries. Ann Rev Neurosci 7: 279–308
Björklund A, Schmidt RH, Stenevi U (1980) Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated suspensions from the substantia nigra. Cell Tissue Res 212: 39–45
Björklund A, Stenevi U, Dunnett SB, Gage FH (1982) Crossspecies neural grafting in a rat model of Parkinson's disease. Nature 298: 652–654
Broadwell RD, Charlton HM, Balin BJ, Salcman M (1987) Angioarchitecture of the CNS, pituitary gland and intracerebral grafts revealed with peroxidase cytochemistry. J Comp Neurol 260: 47–62
Brundin P, Björklund A (1987) Survival, growth and function of dopaminergic neurons grafted to the brain. In: Seil FJ, Herbert E, Carlsson BM (eds) Progress in brain research, Vol 71. Elsevier, Amsterdam, pp 293–308
Brundin P, Nilsson OG, Gage FH, Björklund A (1985) Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res 60: 204–208
Brundin P, Barbin G, Strecker RE, Isacson O, Prochiantz A. Björklund A (1988a) Survival and function of dissociated dopamine neurones grafted at different development stages or after being cultured in vitro. Dev Brain Res 39: 233–243
Brundin P, Strecker RE, Widner H, Clarke DJ, Nilsson OG, Åstedt B, Lindvall O, Björklund A (1988b) Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug induced behaviour, and dopamine release. Exp Brain Res 70: 192–208
Brundin P, Widner H, Nilsson OG, Strecker RE, Björklund A (1989) Intracerebral xenografts of dopamine neurons: the role of immunosupression and the blood-brain barrier. Exp Brain Res 75: 195–207
Brundin P, Strecker RE, Lindvall O, Isacson O, Nilsson OG, Barbin G, Prochiantz A, Forni C, Nieoullon A, Widner H, Gage FH, Björklund A (1987) Intracerebral grafting of dopamine neurons: experimental basis for a clinical application in patients with Parkinson's disease. Ann NY Acad Sci 495: 473–496
Daniloff JK, Low WC, Bodony RP, Wells J (1985) Cross-species neural transplants of embryonic septal nuclei to the hippocampal formation of adult rats. Exp Brain Res 59: 73–82
Date I, Kawamura K, Nakashima H (1988) Histological signs of immune reactions against allogeneic solid neural grafts in the mouse cerebellum depend on the MHC locus. Exp Brain Res 73: 15–22
Fine A, Hunt SP, Oertel WH, Nomoto M, Chong PN, Bond A, Waters C, Temlett JA, Annett L, Dunnett S, Jenner P, Marsden CD (1988) Transplantation of embrionic marmoset dopaminergic neurons to the corpus stritum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6,-tetra-hydropyridine. In: Gash DM, Sladek JR Jr (eds) Progress in brain research, Vol 78. Elsevier, Amsterdam, pp 479–490
Finsen B, Poulsen PH, Zimmer J (1988) Xenografting of fetal mouse hippocampal tissue to the brain of adult rats: effect of cyclosporin A treatment. Exp Brain Res 70: 117–133
Freed CR, Richards JB, Hutt C, Whalen J, Peterson R, Reite M (1987) Behavioural effects of fetal dopamine cell transplantation in bonnet monkeys with MPTP-induced parkinsonism. Soc Neurosci Abstr 219.5
Freed WJ (1983) Functional brain tissue transplantation: reversal of lesion-induced rotation by intraventricular substantia nigra and adrenal medulla grafts, with a note on intracranial retinal grafts. Biol Psychiat 18: 1205–1267
Geyer SJ, Gill TJ (1979) Immunogenetic aspects of intracerebral skin transplanted in inbred rats. Am J Path 94: 569–579
Geyer SJ, Gill TJ, Kunz HW, Moody E (1985) Immunogenetic aspects of transplantation in the rat brain. Transplantation 39: 244–247
Greene HSN (1953) The transplantation of human brain tumors to the brains of laboratory animals. Cancer Res 13: 422–426
Hasek M, Chutna J, Sladecek M, Lodin Z (1977) Immunological tolerance and tumour allografts in the brain. Nature 268: 68–69
Head JR, Griffin ST (1985) Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege. Proc R Soc Lond B 224: 375–387
Hildeman WH (1970) Components and concepts of antigenic strength. Transplant Rev 3: 5–22
Inoue H, Kohsaka S, Yoshida K, Ohtani M, Toya S, Tsukada Y (1985) Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of rat brain. Neurosci Lett 54: 85–90
Kamo H, Kim SU, McGeer PL, Shin DH (1986) Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons. Brain Res 397: 372–376
Klein J (1975) Biology of the mouse histocompatibility-2-complex. Springer, Berlin, pp 1–536
Klein J, Juretic A, Baxevanis CN, Nagy Z (1981) The traditional and a new version of the mouse H-2 complex. Nature 291: 455–460
Lampson LA (1987) Molecular bases of the immuno response to neural antigens. Trends Neurosci 10: 211–216
Lampson LA, Fischer CA (1984) Weak HLA and β2-microglobulin expression of neuronal cell lines can be modulated by interferon. Proc Natl Acad Sci USA 81: 6476–6480
Lindsay RM, Raisman G (1984) An autoradiographic study of neuronal development, vascularization and glial cell migration from hippocampal transplants labeled in intermediate explant culture. Neuroscience 12: 513–530
Lindvall O, Dunnett SB, Brundin P, Björklund A (1987) Transplantation of catecholamine-producing cells to the basal ganglia in Parkinson's disease: experimental and clinical studies. In: Rose CF (ed) Parkinsons' disease: clinical and experimental advances. John Libbey and Co Ltd, London, pp 189–206
Lodin Z, Hasek M, Chutna J, Sladecek M, Holan V (1977) Transplantation immunity in the brain. J Neurolog Sci 3: 577–581
Lorén I, Björklund A, Falck B, Lindvall O (1980) The aluminium formaldehyde (ALFA) method for improved visualization of catecholamines an indoleamines. I. A detailed account of the methodology for central nervous tissue using paraffin, cryostat or vibratome sections. J Neurosci Meth 2: 277–300
Loveland B, Simpson E (1987) The non-MHC transplantation antigens: neither weak nor minor. Immunol Today 7–8: 223–229
Low WC, Lewis PR, Bunch ST (1983) Embryonic neural transplants across a major histocompatibility barrier: survival and specificity of innervation. Brain Res 262: 328–333
Lund RD, Rao K, Hankin MH, Kunz HW, Gill TJ (1987) Transplantation of retina and visual cortex to rat brains of different ages. Maturation, connection patterns, and immunological consequences. Ann N Y Acad Sci 495: 227–241
Mason DW, Charlton HM, Jones AJ, Lavy CB, Pukalavec M (1986) The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents. Neuroscience 19: 685–694
Medawar PB (1948) Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29: 58–69
Murphy JB, Sturm E (1923) Conditions determining the transplantability of tissues in the brain. J Exp Med 38: 183–197
Nicholas MK, Antel JP, Stefansson K, Arnason BDW (1987) Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol 139: 2275–2283
Olson L, Backlund EO, Freed WJ, Herrera-Marschitz M, Hoffer B, Seiger Å, Strömberg I (1985) Transplantation of monoamine producing cell systems in oculo and intracranially: experiments in search of a treatment for Parkinson's disease. Ann N Y Acad Sci 457: 105–126
Raju S, Grogan JB (1977) Immunologic study of the brain as a privileged site. Transplant Proc 9: 1187–1191
Scheinberg LC, Edelman FL, Levy AW (1964) Is the brain an immunologically privileged-site? Arch Neurol 11: 248–264
Simonsen M (1962) Graft versus host reactions: their natural history, and applicability as tools of research. Prog Allergy 6: 349–467
Sladek JR, Collier TJ, Habner SN, Roth RH, Redmond DE (1986) Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res Bull 17: 809–818
Vinogradova OS, Bragin AG, Kitchigina VF (1985) Spontaneous and evoked activity of neurons in intrabrain allo and xenografts of the hippocampus and septum. In: Björklund A, Stenevi U (eds) Neural grafting in the mammalian CNS. Elsevier, Amsterdam, pp 409–421
Weir DM (1978) Handbook of experimental immunology, Vol 3. Applications of immunological methods. Blackwell Scientific Publications, Oxford, pp A4.10-A4.11
Widner H, Brundin P (1988) Immunological aspects of grafting in the mammalian central nervous system: a review and speculative synthesis. Brain Res Rev 13: 287–324
Widner H, Möller G, Johansson BB (1988) Immune response in deep cervical lymph nodes and spleen after antigen deposition in different intracerebral sites. Scand J Immunol 28: 563–572
Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310: 688–691
Zalewski AA, Goshgarian HG, Silvers WK (1978) The fate of neurons and neurilemmal cells in the spinal cord of normal and immunologically tolerant rats. Exp Neurol 59: 322–330
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Widner, H., Brundin, P., Björklund, A. et al. Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice. Exp Brain Res 76, 187–197 (1989). https://doi.org/10.1007/BF00253636
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00253636